Lancet 402 , 693704 (2023)
Take Charge of Your Health With MedHealth360
Moving forward, it is important for clinicians to be aware of the possibility of known or novel injection-site reactions in response to GLP-1RAs
The abbreviated processes used by some telehealth companies were simply not designed to catch the different levels of risk
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Its not uncommon for new medications to cause some initial disruption as your body adjusts